Intellectual property law and access to medicines : TRIPS Agreement, health, and pharmaceuticals /
| Corporate Author: | |
|---|---|
| Other Authors: | , |
| Format: | eBook |
| Language: | English |
| Published: |
Abingdon, Oxon ; New York, NY :
Routledge,
2021.
|
| Series: | Law, development and globalization.
|
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
Table of Contents:
- Introduction
- World Trade Organization : a barrier to global public health? / Srividhya Ragavan
- World Health Organization : contributions to access to health and TRIPS agreement discourse / Susan Isiko Štrba
- From TRIPS to access to medicines : what's there in between? / Sergio Napolitano
- Free trade agreements : longer, further, deeper impact on pharmaceutical patents / Bryan Mercurio
- From the TPP to USMCA : a high-powered battle over biologics / Burcu Kilic
- African union continental free trade area : opportunities for new regional discourse? / J. Janewa Osei-Tutu
- U.S. litigated government funded patents in Europe and Japan : a first look / Teo Firpo and Michael S. Mireles
- Brazil : patent barriers and access to medicine through public health system / Gabriela Costa Chaves, Maria Auxiladora Oliveira, and Jorge Antonio Zepeda Bermudez
- China : from struggle to surge : China's TRIPS experience and its lessons for access to medicines / Peter K. Yu
- Canada : access to medicine in high-income countries / Gaëlle Groux and Jeremy de Beer
- India : pharmaceutical patents and evergreen battle for access to medicine / Anand Grover
- South Africa's three decades of access to medicine discourse : blight or benefit / Caroline B. Ncube
- Thailand : shooting star for access to medicine through compulsory licensing / Van Anh Le
- United States : unilateral norm setting using Special 301 / Michael Palmedo
- Access to medicines activism : collaboration, conflicts, and complementarities / Brook K. Baker
- GTPI : experiences to overcome ip barriers to increase access to medicine / Felipe de Carvalho Borges da Fonseca, Marcela Fogaça Vieira, and Pedro Villardi
- Private sector : right to health responsibilities of pharmaceutical companies / Emmanuel Kolawole Oke
- Competition : can excessive pricing be fixed through abuse of dominant position? / Shirin Syed
- The unique world of pharmaceutical intellectual property rights / Emily Michiko Morris
- Innovation policies : roadblocks to establishing sustainable pharmaceutical innovation policies / Doris Estelle Long
- Not Just patents and data exclusivity : the role of trademarks in integrated IP strategy -where lies the public interest? / Graham Dutfield
- Indigenous knowledge : bridging with modern medicine / Anthony C. K. Kakooza
- Digital divide and access to medicine : the debate / Swaraj Paul Barooah
- Lessons from COVID-19 for medicine access / Amaka Vanni.